Reneo Pharmaceuticals, Inc.

NASDAQ:RPHM

18.2 (USD) • At close October 4, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 000.734000000000000000
Kosten van de omzet 0.0120.0160.0440.0430.1630.1610.1280.1190.0220.0190.0170.0130.010.010000
Brutowinst -0.012-0.0160.69-0.043-0.163-0.161-0.128-0.119-0.022-0.019-0.017-0.013-0.01-0.010000
Brutowinstmarge 000.94000000000000000
Onderzoek- en ontwikkelingskosten 0.5784.92617.5613.62214.410.99110.3579.9388.1329.2787.19.3186.2795.4725.1184.4312.8173.578
Algemene en administratieve kosten 5.7744.6227.4027.2666.6395.1324.2053.9024.2993.7373.5243.4342.9491.7421.1330.6680.8820.924
Verkoop- en marketingkosten 001.062000000000000000
Verkoop-, algemene en administratieve kosten 5.7744.6228.4647.2666.6395.1324.2053.9024.2993.7373.5243.4342.9491.7421.1330.6680.8820.924
Overige kosten 1.0031.1381.4521.6921.5081.0160.9620.8330.119-0.0210.0170.0170.0120.002-0.0020.0050.0120.071
Bedrijfskosten 6.3529.54826.02420.88821.03916.12314.56213.8412.43113.01510.62412.7529.2287.2146.2515.0993.6994.502
Bedrijfsresultaat -6.364-9.564-26.068-20.888-21.039-16.123-14.562-13.84-12.431-13.015-10.624-12.752-9.228-7.214-6.251-5.099-3.699-4.502
Bedrijfsresultaat ratio 00-35.515000000000000000
Totaal overige inkomsten en kosten netto 1.0031.1382.5141.6921.5081.0160.9620.8330.119-0.0210.0170.0170.0120.002-0.0020.0050.0120.071
Inkomen voor belasting -5.361-8.426-23.554-19.196-19.531-15.107-13.6-13.007-12.312-13.036-10.607-12.735-9.216-7.212-6.253-5.094-3.687-4.431
Inkomen voor belasting ratio 00-32.09000000000000000
Belastingkosten 0-0.0271.059-0.043-0.08-1.016-0.962-0.83300.021-0.017-0.034-0.012-0.0020.004-0.01-0.012-0.071
Nettowinst -5.361-8.426-23.554-19.196-19.531-14.091-12.638-12.174-12.312-13.057-10.607-12.735-9.216-7.212-6.253-5.094-3.687-4.431
Nettowinstmarge 00-32.09000000000000000
WPA (Winst Per Aandeel) -0.16-0.25-0.7-0.57-0.65-0.56-0.52-0.5-0.5-0.53-0.43-0.52-0.43-0.3-0.26-0.65-0.47-0.57
Verwaterde WPA -0.16-0.25-0.7-0.57-0.65-0.56-0.52-0.5-0.5-0.53-0.43-0.52-0.43-0.3-0.26-0.65-0.47-0.57
EBITDA -6.352-9.548-26.024-20.888-20.997-16.082-14.562-13.818-12.409-12.996-10.624-12.739-9.218-7.204-6.241-5.09-3.69-4.493
EBITDA ratio 00-35.455000000000000000